{"id":"oral-l-arginine-aspartate-administration","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":{"chemblId":"CHEMBL6068508","moleculeType":"Small molecule","molecularWeight":"307.31"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"L-arginine serves as a substrate for nitric oxide synthase (NOS), promoting the synthesis of nitric oxide, a critical signaling molecule that regulates vasodilation, blood flow, and endothelial function. The aspartate salt formulation may improve bioavailability and absorption. This mechanism supports improved cardiovascular hemodynamics and tissue perfusion.","oneSentence":"L-arginine aspartate is a nitric oxide precursor that enhances endothelial function and vascular reactivity through increased NO production.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:24:41.675Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Erectile dysfunction"},{"name":"Cardiovascular insufficiency"},{"name":"Endothelial dysfunction"}]},"trialDetails":[{"nctId":"NCT02966665","phase":"PHASE1","title":": Vascular Function in Health and Disease","status":"RECRUITING","sponsor":"Russell Richardson","startDate":"2008-09","conditions":"Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Heart Failure","enrollment":420},{"nctId":"NCT05042024","phase":"PHASE3","title":"Supplementation With L-ornithine But Not L-arginine Increases Density of CD68+ and CD163+ Macrophages in Periodontitis","status":"COMPLETED","sponsor":"Ukrainian Medical Stomatological Academy","startDate":"2017-10-20","conditions":"Periodontitis","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Oral supplementation with Tivortin® Aspartate (Yuria-Pharm, Ukraine)"],"phase":"phase_3","status":"active","brandName":"Oral L-arginine aspartate administration","genericName":"Oral L-arginine aspartate administration","companyName":"Ukrainian Medical Stomatological Academy","companyId":"ukrainian-medical-stomatological-academy","modality":"Small molecule","firstApprovalDate":"","aiSummary":"L-arginine aspartate is a nitric oxide precursor that enhances endothelial function and vascular reactivity through increased NO production. Used for Erectile dysfunction, Cardiovascular insufficiency, Endothelial dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}